| Mr Kevin M Silver, DO | |
|
4381 South Eason Blvd., Suite 202, Tupelo, MS 38801 | |
| (662) 377-6609 | |
| (662) 377-6614 |
| Full Name | Mr Kevin M Silver |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 16 Years |
| Location | 4381 South Eason Blvd., Tupelo, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982934311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 24171 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Mississippi Medical Center | Tupelo, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Mississippi Medical Center Inc | 9931010600 | 295 |
News Archive
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, today announced they have been awarded a Knowledge Transfer Partnership (KTP) grant from Innovate UK, the UK's innovation agency.
In studies in mouse models, researchers at the University of California, San Diego (UCSD) School of Medicine have found that a cellular receptor involved in triggering cell death is also a necessary component of tissue repair and regeneration immediately following liver injury.
Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the Risk Evaluation and Mitigation Strategy (REMS) for FENTORA and ACTIQ.
The importance of computational modeling in the prediction of the course of the ongoing COVID-19 pandemic, as well as evaluating multiple potential drug leads, has never been more clear. Now, a new study describes a set of designer vaccine antigens that may improve vaccine stability as well as enhance the neutralizing antibody response.
› Verified 2 days ago
| Entity Name | North Mississippi Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972608347 PECOS PAC ID: 9931010600 Enrollment ID: O20040413000541 |
News Archive
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, today announced they have been awarded a Knowledge Transfer Partnership (KTP) grant from Innovate UK, the UK's innovation agency.
In studies in mouse models, researchers at the University of California, San Diego (UCSD) School of Medicine have found that a cellular receptor involved in triggering cell death is also a necessary component of tissue repair and regeneration immediately following liver injury.
Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the Risk Evaluation and Mitigation Strategy (REMS) for FENTORA and ACTIQ.
The importance of computational modeling in the prediction of the course of the ongoing COVID-19 pandemic, as well as evaluating multiple potential drug leads, has never been more clear. Now, a new study describes a set of designer vaccine antigens that may improve vaccine stability as well as enhance the neutralizing antibody response.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Kevin M Silver, DO 4381 South Eason Blvd., Suite 202, Tupelo, MS 38801 Ph: (662) 377-6609 | Mr Kevin M Silver, DO 4381 South Eason Blvd., Suite 202, Tupelo, MS 38801 Ph: (662) 377-6609 |
News Archive
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, today announced they have been awarded a Knowledge Transfer Partnership (KTP) grant from Innovate UK, the UK's innovation agency.
In studies in mouse models, researchers at the University of California, San Diego (UCSD) School of Medicine have found that a cellular receptor involved in triggering cell death is also a necessary component of tissue repair and regeneration immediately following liver injury.
Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the Risk Evaluation and Mitigation Strategy (REMS) for FENTORA and ACTIQ.
The importance of computational modeling in the prediction of the course of the ongoing COVID-19 pandemic, as well as evaluating multiple potential drug leads, has never been more clear. Now, a new study describes a set of designer vaccine antigens that may improve vaccine stability as well as enhance the neutralizing antibody response.
› Verified 2 days ago
Brian Edwin Condit, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 609 Brunson Dr, Tupelo, MS 38801 Phone: 662-377-1370 Fax: 662-377-1379 | |
Dr. Victor John Gray, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 218 S Thomas St, Suite 110, Tupelo, MS 38801 Phone: 662-842-4919 Fax: 662-842-9140 | |
Dr. Bruce Edward Porter, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 144 S Thomas St, Building Number 1 Suite 101-2, Tupelo, MS 38801 Phone: 662-841-8830 Fax: 662-841-8832 | |
Dr. Laura Ann Gray, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 905 Garfield St, Tupelo, MS 38801 Phone: 662-842-9677 Fax: 662-842-0309 | |
Mr. Byron Anthony Stutts, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 90a Clark St, Tupelo, MS 38804 Phone: 662-840-0535 Fax: 662-842-7915 |